Proteon logo     Print Page | Close Window

SEC Filings

S-1
PROTEON THERAPEUTICS INC filed this Form S-1 on 09/16/2014
Entire Document
 

Table of Contents

Exhibit No.   Description
  10.24   Indemnification Agreement, dated as of May 13, 2014, by and between the Company and Dmitry Kobyzev.
        
  10.25 †* 2014 Employee Stock Purchase Plan.
        
  10.26 †* Amended and Restated Employment Agreement by and between the Company and Timothy P. Noyes, dated          September 2014.
        
  10.27 †* Amended and Restated Employment Agreement by and between the Company and Steven Burke, dated          September 2014.
        
  10.28 †* Amended and Restated Employment Agreement by and between the Company and George Eldridge, dated          September 2014.
        
  10.29 †* Amended and Restated Employment Agreement by and between the Company and Daniel Gottlieb, dated          September 2014.
        
  21.1   List of Subsidiaries.
        
  23.1 * Consent of Bingham McCutchen LLP (included in Exhibit 5.1).
        
  23.2   Consent of Ernst & Young LLP, independent registered public accounting firm.
        
  24.1   Power of Attorney (included on signature page).

*
To be filed by amendment

Indicates management contract or compensation plan

Indicates confidential treatment has been requested with respect to specific portions of this exhibit. Omitted portions have been filed with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.

(b)   Financial Statement Schedules

        All schedules have been omitted because they are not required or because the required information is given in the financial statements or notes to those statements.

Item 17.    Undertakings.

        The undersigned Registrant hereby undertakes to provide to the underwriters at the closing specified in the underwriting agreement certificates in such denominations and registered in such names as required by the underwriters to permit prompt delivery to each purchaser.

        Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue.

II-5